While MSUD is characterized by the accumulation of leucine, isoleucine, and valine due to mutations in the BCKDH complex, there is a lack of precise information on the mechanism by which the neurological symptoms are caused, thus impeding the development of disease-modifying treatments other than alternative diets [40]. This evidence concerns the gene PPM1K and maple syrup urine disease.